A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

Table 1

Different killing rates of the four groups of CTLs targeting CD90⁺HepG2 and HepG2 cells at various effector/target ratios.

Effector : target	CD90^+HepG2/DC-CTLs		HepG2/DC-CTLs		mDC-CTLs		DC-CTLs
	HepG2	CD90^+HepG2	HepG2	CD90^+HepG2	HepG2	CD90^+HepG2	HepG2	CD90^+HepG2
100 : 1	^b	^c	^b	^c	^b	^c	^b	^c
30 : 1	^a	^c	^a	^c	^a	^c	^a	^c
10 : 1	^a	^c	^a	^c	^a	^c	^a	^c

, , .